TOP NEWS

Dr. Yurochko in the lab

LSUHS has received a 5 year grant for $10,529,128 from the National Institute of Health (NIH) to establish a Center of Biomedical Research Excellence, or COBRE. The COBRE funds will establish the Center for Applied Immunology and Pathological Processes (CAIPP), which will operate on the LSU Health Shreveport campus.

Read More about LSU Health Shreveport awarded over $10.5 million for NIH COBRE focusing research on immunology and pathological processes

MEDIA CONTACTS

Lisa Babin
Executive Director of Communication, Public Affairs and Development
Office: (318) 675-8769
Email: Lisa.Babin@lsuhs.edu

Jazmin Jernigan
Public Relations Coordinator
Office: (318) 675-8789
Email: Jazmin.Jerigan@lsuhs.edu

Megan Strecker, MBA
Research Communications Project Coordinator
Office: (318) 675-4166
Email:
megan.strecker@lsuhs.edu

COVID-19 RELATED NEWS

LSUHS Pandemic Response

LSU Health Shreveport has been on the front line fighting the COVID-19 pandemic since the beginning. The establishment of the Emerging Viral Threats lab in March of 2020 led to mass testing and vaccination sites, clinical trials in patient treatment options and viral sequencing that discovered 7 COVID-19. variants.

Read More about LSUHS Pandemic Response
Ochsner LSU Health Shreveport addresses President Biden’s vaccine mandate for employers with 100 or more workers

KTAL/KMSS - “By November 1st, if people are not vaccinated then they would not be able to work inside of the various Ochsner facilities,” says Dr. Charles Fox, the chief medical officer at Ochsner LSU Health. 

Read More about Ochsner LSU Health Shreveport addresses President Biden’s vaccine mandate for employers with 100 or more workers (opens in new window/tab)
African American Celebration Committee hosts COVID-19 vaccination clinic with LSUHS

KSLA12 - “We can do it. We know there is no reason why we can’t do it. Most of the people who have been hospitalized or have severe disease now have not been vaccinated. We know that getting vaccinated reduces the likelihood that you end up in the hospital, at least 25-fold,” said Former State Representative Barbara Norton.

Read More about African American Celebration Committee hosts COVID-19 vaccination clinic with LSUHS (opens in new window/tab)
LDH reports alarming increase in Severe Pregnancy Outcomes due to COVID-19

KSLA12 - “What we tended to see with the Delta variant is it has impacted our pregnant populations very very hard, especially at the height of the Delta variant we had transfers from all over the state of pregnant woman who were in respiratory distress and significantly decompensating,” said Dr. Caitlin Busada, associate program director of residency of Obstetrics & Gynecology at LSUHS.

Read More about LDH reports alarming increase in Severe Pregnancy Outcomes due to COVID-19 (opens in new window/tab)
FDA review of Pfizer data for child vaccinations could take weeks

KTBS3 - Dr. John Vanchiere, the lead investigator in the Pfizer vaccine study at LSUHS said, “We expect that to take at least four to six weeks of time. And Pfizer and Moderna are both starting additional enrollment in the pediatric studies in that 5- to 11-year-old age range, so that they can get more data under the research protocol to submit to the FDA when it’s appropriate.”

Read More about FDA review of Pfizer data for child vaccinations could take weeks (opens in new window/tab)
Immunobridging data used in Pfizer vaccine study for kids

KTBS3 - Dr. John Vanchiere, an infectious disease and pediatrics specialist and the lead investigator on the Pfizer vaccine study at LSU Health Shreveport, shares "Demonstrating effectiveness that is preventing hospitalization and death or severe disease is very challenging in the pediatric population, because kids don't get generally very sick."

Read More about Immunobridging data used in Pfizer vaccine study for kids (opens in new window/tab)
Delta’s highly infectious nature positions it to outcompete new variants, scientists say

Wall Street Journal - Some virologists believe the Delta variant evolved to maximize transmissibility and that its ability to spread rapidly will eventually reach a ceiling as more of the global population gets vaccinated. “It looks like this virus is already driving a Lamborghini right now in terms of transmissibility, so I’m not sure it can get much faster,” said Jeremy Kamil, a virologist at LSU Health Shreveport who is studying coronavirus genetics. Read the full article.

Read More about Delta’s highly infectious nature positions it to outcompete new variants, scientists say (opens in new window/tab)

 

Agilent Seahorse XFe24 Analyzer

RESEARCH NEWS

Read More

Faculty, staff and students are actively engaged in research in a variety of biomedical areas, with concentrations in cancer, cardiovascular sciences, virology and neuroscience.

Dr. Yurochko receiving award from Dr. Kevil

HONORS NEWS

Read More

We’re proud to have students, residents, staff and faculty who serve in leadership positions and who are recognized for their work at state, national and international levels.

student in library aisle

EDUCATION NEWS

Read More

The next generation of doctors, allied health professionals and scientists are being trained at LSU Health Shreveport, one of three academic health sciences centers in Louisiana.

Elbow bump at vaccine site

COMMUNITY NEWS

Read More

Being part of our community is important to us. We regularly host events on our campus that are open to everyone.

MEDIA INFORMATION

If you are a member of the media interested in learning more about LSU Health Shreveport, need to interview an expert for a story, or have an idea for a story you’d like to discuss, please contact our Communications team. We are happy to answer your questions and look forward to working with you!

 

PRESS RELEASES   FACT SHEET   

CONTACT OUR COMMUNICATIONS TEAM

LSU Health Shreveport Campus

LSUHS Newsroom

For the Latest LSUHS News & Media Stories